FYERS
Home
/
Stocks
/
Results
/
Caplin Point Laboratories Results

Caplin Point Laboratories Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
25%16%14%13%
30%21%19%20%
26%26%41%24%
31%23%22%21%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
CAPLIPOINT
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
2,867.4₹21217 Cr31.8923.2897.81₹641 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Revaluation reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011
————————————————
₹90 Cr₹90 Cr₹90 Cr₹90 Cr₹90 Cr₹90 Cr₹90 Cr₹51 Cr₹15 Cr₹15 Cr₹15 Cr₹15 Cr₹15 Cr₹15 Cr₹15 Cr₹15 Cr
₹18 Cr₹20 Cr₹14 Cr₹15 Cr₹15 Cr₹15 Cr₹9 Cr₹7 Cr₹3 Cr₹9 L₹2 Cr₹0₹0₹0₹0₹0
₹3478 Cr₹2741 Cr₹2212 Cr₹1775 Cr₹1379 Cr₹1081 Cr₹849 Cr₹575 Cr₹345 Cr₹210 Cr₹111 Cr₹78 Cr₹47 Cr₹28 Cr₹18 Cr₹14 Cr
₹3478 Cr₹2741 Cr₹2212 Cr₹1775 Cr₹1379 Cr₹1081 Cr₹849 Cr₹575 Cr₹345 Cr₹210 Cr₹108 Cr₹74 Cr₹43 Cr₹24 Cr₹15 Cr₹10 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
₹3586 Cr₹2850 Cr₹2316 Cr₹1880 Cr₹1484 Cr₹1186 Cr₹948 Cr₹633 Cr₹364 Cr₹225 Cr₹128 Cr₹93 Cr₹62 Cr₹43 Cr₹34 Cr₹29 Cr
₹44 Cr₹36 Cr₹31 Cr₹27 Cr₹26 Cr₹18 Cr₹9 Cr₹8 L₹9 L₹36 L₹27 L₹27 L₹18 L₹9 L₹5 L₹3 L
₹0₹0₹0₹0₹0₹0₹2 L₹29 L₹32 L₹48 L₹73 L₹88 L₹2 Cr₹3 Cr₹2 Cr₹8 L
₹5 Cr-₹2 Cr-₹13 Cr-₹14 Cr-₹6 Cr₹1 Cr₹10 Cr₹18 Cr₹22 Cr₹19 Cr₹11 Cr₹9 Cr₹8 Cr₹5 Cr₹2 Cr₹2 Cr
₹15 Cr₹14 Cr₹11 Cr₹8 Cr₹10 Cr₹11 Cr₹10 Cr₹5 Cr₹5 Cr₹5 L₹0₹0₹0₹0₹0₹0
₹1 Cr₹2 Cr₹9 Cr₹8 Cr₹8 Cr₹6 Cr₹5 Cr₹13 L₹0₹40 L₹2 Cr₹82 L₹81 L₹38 L₹27 L₹20 L
₹21 Cr₹13 Cr₹8 Cr₹2 Cr₹13 Cr₹17 Cr₹25 Cr₹23 Cr₹28 Cr₹20 Cr₹14 Cr₹10 Cr₹10 Cr₹9 Cr₹4 Cr₹2 Cr
————————————————
₹296 Cr₹218 Cr₹230 Cr₹153 Cr₹156 Cr₹89 Cr₹64 Cr₹60 Cr₹94 Cr₹79 Cr₹56 Cr₹42 Cr₹32 Cr₹26 Cr₹21 Cr₹17 Cr
₹69 Cr₹64 Cr₹90 Cr₹100 Cr₹49 Cr₹52 Cr₹79 Cr₹24 Cr₹14 Cr₹33 Cr₹60 Cr₹72 Cr₹66 Cr₹51 Cr₹38 Cr₹11 Cr
₹57 L₹55 L₹28 L₹3 Cr₹50 L₹0₹0₹0₹0₹0₹0₹5 L₹5 L₹5 L₹5 Cr₹9 Cr
₹20 Cr₹24 Cr₹11 Cr₹12 Cr₹3 Cr₹2 Cr₹91 L₹1 Cr₹58 L₹2 Cr₹9 Cr₹11 Cr₹10 Cr₹6 Cr₹4 Cr₹3 Cr
₹386 Cr₹306 Cr₹331 Cr₹268 Cr₹208 Cr₹143 Cr₹144 Cr₹86 Cr₹109 Cr₹113 Cr₹125 Cr₹125 Cr₹108 Cr₹83 Cr₹69 Cr₹40 Cr
₹4038 Cr₹3206 Cr₹2686 Cr₹2177 Cr₹1730 Cr₹1364 Cr₹1126 Cr₹743 Cr₹500 Cr₹358 Cr₹267 Cr₹229 Cr₹180 Cr₹135 Cr₹107 Cr₹71 Cr
₹18 Cr₹64 L₹64 L₹64 L₹71 L₹1 Cr₹1 Cr₹1 Cr₹3 Cr₹4 Cr₹5 Cr₹7 Cr₹8 Cr₹3 Cr₹4 Cr₹3 Cr
₹57 L₹55 L₹28 L₹3 Cr₹50 L₹17 Cr₹36 Cr₹54 L₹54 L₹72 L₹2 Cr₹2 Cr₹3 Cr₹5 Cr₹7 Cr₹10 Cr
————————————————
₹965 Cr₹859 Cr₹702 Cr₹480 Cr₹446 Cr₹423 Cr₹355 Cr₹272 Cr₹232 Cr₹195 Cr₹181 Cr₹143 Cr₹123 Cr₹50 Cr₹43 Cr₹40 Cr
₹385 Cr₹313 Cr₹250 Cr₹201 Cr₹159 Cr₹117 Cr₹82 Cr₹45 Cr₹62 Cr₹43 Cr₹37 Cr₹30 Cr₹21 Cr₹17 Cr₹16 Cr₹15 Cr
₹580 Cr₹546 Cr₹453 Cr₹280 Cr₹287 Cr₹305 Cr₹273 Cr₹227 Cr₹169 Cr₹152 Cr₹144 Cr₹113 Cr₹102 Cr₹33 Cr₹28 Cr₹25 Cr
₹209 Cr₹139 Cr₹117 Cr₹220 Cr₹15 Cr₹14 Cr₹20 Cr₹10 Cr₹15 Cr₹3 Cr₹23 L₹30 Cr₹24 Cr₹49 Cr₹13 Cr₹17 L
₹473 Cr₹279 Cr₹138 Cr₹71 Cr₹37 Cr₹66 L₹56 L₹33 L₹33 L₹13 Cr₹44 L₹45 L₹44 L₹1 Cr₹1 Cr₹1 Cr
₹473 Cr₹279 Cr₹138 Cr₹71 Cr₹37 Cr₹66 L₹56 L₹33 L₹33 L₹13 Cr₹44 L₹45 L₹44 L₹1 Cr₹1 Cr₹1 Cr
₹151 Cr₹89 Cr₹78 Cr₹52 Cr₹90 Cr₹8 Cr₹10 Cr₹12 Cr₹11 Cr₹11 Cr₹4 Cr₹3 Cr₹4 Cr₹11 Cr₹12 Cr₹4 Cr
₹14 Cr₹15 Cr₹7 Cr₹3 Cr₹1 Cr₹21 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹1452 Cr₹1072 Cr₹793 Cr₹625 Cr₹432 Cr₹349 Cr₹303 Cr₹249 Cr₹196 Cr₹179 Cr₹149 Cr₹147 Cr₹131 Cr₹96 Cr₹53 Cr₹30 Cr
————————————————
₹386 Cr₹311 Cr₹238 Cr₹210 Cr₹52 Cr₹11 Cr₹60 Cr₹70 Cr₹46 Cr₹4 Cr₹0₹0₹0₹0₹0₹0
₹429 Cr₹336 Cr₹363 Cr₹288 Cr₹227 Cr₹179 Cr₹238 Cr₹37 Cr₹28 Cr₹22 Cr₹19 Cr₹14 Cr₹10 Cr₹10 Cr₹6 Cr₹5 Cr
₹826 Cr₹632 Cr₹543 Cr₹394 Cr₹317 Cr₹279 Cr₹229 Cr₹160 Cr₹126 Cr₹33 Cr₹8 Cr₹6 Cr₹9 L₹86 L₹7 Cr₹8 Cr
₹621 Cr₹591 Cr₹553 Cr₹493 Cr₹463 Cr₹438 Cr₹223 Cr₹153 Cr₹79 Cr₹93 Cr₹68 Cr₹45 Cr₹27 Cr₹17 Cr₹32 Cr₹22 Cr
₹98 Cr₹77 Cr₹50 Cr₹23 Cr₹14 Cr₹20 Cr₹15 Cr₹9 Cr₹7 Cr₹7 Cr₹11 Cr₹6 Cr₹4 Cr₹5 Cr₹4 Cr₹2 Cr
₹226 Cr₹186 Cr₹146 Cr₹143 Cr₹225 Cr₹87 Cr₹57 Cr₹65 Cr₹17 Cr₹19 Cr₹13 Cr₹11 Cr₹8 Cr₹6 Cr₹4 Cr₹3 Cr
₹2586 Cr₹2134 Cr₹1893 Cr₹1552 Cr₹1298 Cr₹1015 Cr₹823 Cr₹494 Cr₹304 Cr₹179 Cr₹119 Cr₹82 Cr₹49 Cr₹39 Cr₹54 Cr₹41 Cr
₹2200 Cr₹1828 Cr₹1562 Cr₹1284 Cr₹1090 Cr₹872 Cr₹678 Cr₹408 Cr₹195 Cr₹66 Cr-₹7 Cr-₹43 Cr-₹59 Cr-₹44 Cr-₹15 Cr₹81 L
₹4038 Cr₹3206 Cr₹2686 Cr₹2177 Cr₹1730 Cr₹1364 Cr₹1126 Cr₹743 Cr₹500 Cr₹358 Cr₹267 Cr₹229 Cr₹180 Cr₹135 Cr₹107 Cr₹71 Cr
₹460₹363₹293₹236₹184₹145₹114₹78₹48₹30₹81₹59₹38₹26₹20₹17
₹460₹363₹293₹236₹184₹145₹114₹78₹48₹30₹16₹12₹8₹5₹4₹3

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Jun 2015Jun 2014Jun 2013Jun 2012Jun 2011
₹803 Cr₹677 Cr₹564 Cr₹451 Cr₹386 Cr₹314 Cr₹269 Cr₹227 Cr₹188 Cr₹121 Cr₹60 Cr₹53 Cr₹36 Cr₹22 Cr₹11 Cr₹8 Cr
-₹26 Cr₹6 Cr₹2 Cr₹12 Cr₹30 Cr₹23 Cr₹7 Cr₹19 Cr₹15 Cr₹9 Cr₹4 Cr₹6 Cr₹2 Cr-₹21 L-₹25 L₹2 Cr
-₹109 Cr-₹122 Cr-₹139 Cr-₹104 Cr₹2 Cr-₹2 Cr-₹177 Cr-₹120 Cr-₹100 Cr-₹38 Cr-₹5 Cr₹2 Cr₹29 Cr₹16 Cr₹19 Cr₹4 Cr
₹668 Cr₹560 Cr₹427 Cr₹359 Cr₹418 Cr₹335 Cr₹99 Cr₹126 Cr₹103 Cr₹91 Cr₹59 Cr₹62 Cr₹67 Cr₹38 Cr₹30 Cr₹15 Cr
₹523 Cr₹432 Cr₹318 Cr₹271 Cr₹337 Cr₹269 Cr₹45 Cr₹83 Cr₹66 Cr₹68 Cr₹42 Cr₹50 Cr₹60 Cr₹32 Cr₹28 Cr₹14 Cr
-₹582 Cr-₹335 Cr-₹320 Cr-₹218 Cr-₹377 Cr-₹29 Cr-₹55 Cr-₹100 Cr-₹69 Cr-₹36 Cr-₹6 Cr-₹23 Cr-₹44 Cr-₹45 Cr-₹16 Cr-₹7 Cr
-₹46 Cr-₹38 Cr-₹38 Cr-₹28 Cr-₹41 Cr-₹24 Cr₹80 Cr₹90 Cr-₹12 Cr-₹7 Cr-₹14 Cr-₹9 Cr-₹6 Cr-₹1 Cr-₹1 Cr-₹37 L
-₹106 Cr₹59 Cr-₹40 Cr₹26 Cr-₹81 Cr₹215 Cr₹70 Cr₹73 Cr-₹14 Cr₹25 Cr₹23 Cr₹19 Cr₹10 Cr-₹15 Cr₹10 Cr₹7 Cr
₹199 Cr₹139 Cr₹178 Cr₹151 Cr₹232 Cr₹221 Cr₹151 Cr₹77 Cr₹91 Cr₹67 Cr₹45 Cr₹27 Cr₹17 Cr₹32 Cr₹22 Cr₹15 Cr
-₹8 Cr-₹6 Cr-₹5 Cr-₹7 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹25 L₹1 Cr₹86 L₹1 Cr-₹9 L-₹24 L₹17 L₹72 L-₹80,000₹0₹0₹0₹0₹0₹0₹0
₹87 Cr₹194 Cr₹134 Cr₹171 Cr₹151 Cr₹436 Cr₹221 Cr₹151 Cr₹77 Cr₹91 Cr₹68 Cr₹45 Cr₹27 Cr₹17 Cr₹32 Cr₹22 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)2,775.00
Volume (₹)12.41 L
High (₹)2,990.00
Upper Circuit3,352.50
Low (₹)2,770.00
Lower Circuit2,235.10
Prev Close2,793.80
52W High (₹)2,990.00
Price2,867.40
52W Low (₹)1,500.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)21217.10 Cr
Div. Yield (%)0.29
PE Ratio31.89
Debt to Equity0.00
Price to Book3.27
Book Value459.68
EPS (TTM)87.53
Face Value2.00
ROE (%)20.79

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
CAPLIPOINTNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
2867.4+118.8 (4.32%)
2749
2990
21,217Cr

Caplin Point Laboratories Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹247.03Cr; with other income of ₹33.55Cr, profit before interest and tax came to ₹225.41Cr. Interest expense was ₹18Lakh; PBT before exceptional items stood at ₹225.23Cr. Cost mix (full year): raw materials ₹732.28Cr; employee cost ₹177.15Cr; depreciation ₹21.62Cr; other expenses ₹396.88Cr. Basis: consolidated annual results.

Caplin Point Laboratories Ltd Quaterly Results Key Takeaways

Caplin Point Laboratories Ltd reported ₹610.36Cr total income from operations in Jun 2026, softer than ₹600.16Cr in Mar 2026 but higher than ₹510.22Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹247.03Cr; with other income of ₹33.55Cr, profit before interest and tax came to ₹225.41Cr. Interest expense was ₹18Lakh, taking profit before tax to ₹225.23Cr. After tax of ₹46.13Cr, profit after tax stood at ₹179.1Cr (vs ₹172.88Cr in Mar 2026 and ₹150.73Cr in Jun 2025).